These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10741073)

  • 1. [Which lipid class for which lipid disorder?].
    Wasielewski S
    Med Monatsschr Pharm; 2000 Mar; 23(3):94-6. PubMed ID: 10741073
    [No Abstract]   [Full Text] [Related]  

  • 2. [Management of hyperlipemia. When to administer agents that regulate lipid disorders?].
    Cybulska B
    Kardiol Pol; 1991; 35(8):107-15. PubMed ID: 1942755
    [No Abstract]   [Full Text] [Related]  

  • 3. Current drug treatments for lipid management.
    Stone NJ
    Manag Care; 2002 Sep; 11(9 Suppl):4-9. PubMed ID: 12369341
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperlipidemia: treatment with lipid-lowering agents.
    LaRosa JC
    Md Med J; 1988 May; 37(5):401-6. PubMed ID: 3386426
    [No Abstract]   [Full Text] [Related]  

  • 5. Drugs for lipid disorders.
    Treat Guidel Med Lett; 2003 Aug; 1(12):77-82. PubMed ID: 15529095
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cerivastatine--profile of a new lipid-reducing drug].
    Internist (Berl); 1998 Jan; 39(1 Suppl Cerivastat):1-8. PubMed ID: 9509018
    [No Abstract]   [Full Text] [Related]  

  • 7. [Can we really reach our goals? Arguments for aggressive lipid lowering].
    Internist (Berl); 1999 Sep; 40(9 Suppl Argumente):1-8. PubMed ID: 10528586
    [No Abstract]   [Full Text] [Related]  

  • 8. Improvement in current approaches to lipid lowering.
    Ansell BJ
    Am Fam Physician; 2002 Mar; 65(5):783, 786-7. PubMed ID: 11898952
    [No Abstract]   [Full Text] [Related]  

  • 9. A vote of no confidence in the precision of the estimated cost-effectiveness of lipid lowering.
    Wilcock M
    Br J Gen Pract; 2000 Nov; 50(460):917-8. PubMed ID: 11141882
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypolipidaemic agents (author's transl)].
    Tillement JP; Albengres E; Choisy H; Millart H
    Nouv Presse Med; 1980 Oct; 9(40):2947-50. PubMed ID: 7443428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving lipid goal attainment: is it enough?
    Gotto AM
    Circulation; 2009 Jul; 120(1):3-5. PubMed ID: 19546383
    [No Abstract]   [Full Text] [Related]  

  • 12. [Guidelines for lipid-lowering therapy. Results of the 2d Consensus Conference of the European Atherosclerosis Society. Press conference. London, 6 May 1988].
    Fortschr Med Suppl; 1988; 46():1-22. PubMed ID: 2905324
    [No Abstract]   [Full Text] [Related]  

  • 13. [How sure is the combined lipid lowering?].
    Schäfer J
    MMW Fortschr Med; 2005 Jan; 147(1-2):56. PubMed ID: 15704576
    [No Abstract]   [Full Text] [Related]  

  • 14. Does lipid-lowering therapy slow progression of chronic kidney disease?
    Wheeler DC
    Am J Kidney Dis; 2004 Nov; 44(5):917-20. PubMed ID: 15492960
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipid-lowering drugs: French prescribers under pressure.
    Prescrire Int; 2002 Oct; 11(61):158. PubMed ID: 12378750
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipid management in Type 1 diabetes.
    Pachaiappan KJ; Patel V; Morrissey J; Gadsby R
    Diabet Med; 2006 Mar; 23 Suppl 1():11-4. PubMed ID: 16483259
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antilipemic agents].
    Harlay A
    Infirm Fr; 1975 Apr; (164):29-30. PubMed ID: 1039004
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fliformine effects on blood lipid spectrum and lipid peroxidation in obese patients].
    Ageeva VV; Krasil'nikova EI; Zubina IM; Shliakhto EV
    Klin Med (Mosk); 2000; 78(10):46-9. PubMed ID: 11220901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-lowering drugs and changes to diet can make a difference.
    TreatmentUpdate; 2001 Aug; 13(4):7-9. PubMed ID: 11590981
    [No Abstract]   [Full Text] [Related]  

  • 20. [New drug against lipid disorders. HDL level rises 30%].
    MMW Fortschr Med; 2003 Sep; 145(39):51. PubMed ID: 14649076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.